Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/32570
Full metadata record
DC FieldValueLanguage
dc.contributor.authorColomer Bosch, Ramón-
dc.contributor.authorAlba, Emilio-
dc.contributor.authorGonzález-Martin, Antonio-
dc.contributor.authorPaz-Ares, Luis-
dc.contributor.authorMartín, Miguel-
dc.contributor.authorLlombart Bosch, Antonio-
dc.contributor.authorRodríguez-Lescure, Álvaro-
dc.contributor.authorSalvador Bofill, Javier-
dc.contributor.authorAlbanell Mestres, Joan-
dc.contributor.authorIsla, Dolores-
dc.contributor.authorLomas, María-
dc.contributor.authorRodríguez, César A.-
dc.contributor.authorTrigo, José Manuel-
dc.contributor.authorGermà Lluch, José Ramón-
dc.contributor.authorBellmunt Molins, Joaquim, 1959--
dc.contributor.authorTabernero Caturla, Josep-
dc.contributor.authorRosell Costa, R.-
dc.contributor.authorAranda, Enrique-
dc.contributor.authorCubedo, Ricardo-
dc.contributor.authorBaselga Torres, Josep, 1959--
dc.contributor.authorSpanish Society of Medical Oncology-
dc.date.accessioned2012-11-07T12:45:32Z-
dc.date.available2012-11-07T12:45:32Z-
dc.date.issued2010-02-01-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/2445/32570-
dc.description.abstractCancer treatment involves the participation of multiple medical specialties and, as our knowledge of the disease increases, this fact becomes even more apparent. The degree of multidisciplinarity is determined by several factors, which include the severity and type of disease, the increasing diversity in the available pharmacological and non-pharmacological therapies, and the range of specialists involved in cancer therapy, such as medical oncologists, radiotherapists, gynecologists, gastroenterologists, urologists, surgeons, and pneumologists, among others. Across Europe, the situation of cancer care can be variable due to the diversity of health systems, differences in drug reimbursement, and the degree of establishment of Medical Oncology as a medical specialty in the European Union states.-
dc.format.extent4 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengeng
dc.publisherOxford University Press-
dc.relation.isformatofDocument publicat a: http://dx.doi.org/10.1093/annonc/mdp595-
dc.relation.ispartofAnnals of Oncology, 2010, vol. 21, num. 2, p. 195-198-
dc.relation.urihttp://dx.doi.org/10.1093/annonc/mdp595-
dc.rightscc-by-nc (c) Colomer et al., 2010-
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationCàncercat
dc.subject.classificationMedicació oralcat
dc.subject.otherCancereng
dc.subject.otherOral medicationeng
dc.titleTreatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncologyeng
dc.typeinfo:eu-repo/semantics/articleeng
dc.typeinfo:eu-repo/semantics/publishedVersioneng
dc.identifier.idgrec590202-
dc.date.updated2012-11-07T12:45:32Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesseng
dc.identifier.pmid20110291-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
590202.pdf68.36 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons